GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Alimentary Pharmacology & Therapeutics, Wiley, Vol. 60, No. 1 ( 2024-07), p. 43-51
    Abstract: Endoscopic healing (EH) is a therapeutic target in ulcerative colitis (UC). However, even patients who have achieved EH relapse frequently. Aims To investigate the association between recent steroid use and relapse risk in UC patients with EH. Methods This multi‐centre cohort study included 1212 UC patients with confirmed EH (Mayo endoscopic subscore ≤1). We excluded patients with current systemic steroid use or history of advanced therapy. We divided patients into a recent steroid group (last systemic steroid use within 1 year; n = 59) and a non‐recent or steroid‐naïve group ( n = 1153). We followed the patients for 2 years to evaluate relapse, defined as induction of systemic steroids or advanced therapy. We used logistic regression to estimate the odds ratio (OR) of relapse. Results Relapse occurred in 28.8% of the recent steroid group and 5.6% of the non‐recent/steroid‐naïve group (multi‐variable‐adjusted OR 5.53 [95% CI 2.85–10.7]). The risk of relapse decreased with time since the last steroid use: 28.8% for less than 1 year after steroid therapy, 22.9% for 1 year, 16.0% for 2 years and 7.9% beyond 3 years, approaching 4.0% in steroid‐naïve patients. ( p trend 〈 0.001). Conclusions Even for patients with UC who achieved EH, the risk of relapse remains high following recent steroid therapy. Physicians need to consider the duration since last steroid use to stratify the relapse risk in UC patients with EH.
    Type of Medium: Online Resource
    ISSN: 0269-2813 , 1365-2036
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2024
    detail.hit.zdb_id: 2003094-0
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: British Journal of Pharmacology, Wiley, Vol. 131, No. 6 ( 2000-11), p. 1204-1210
    Abstract: Cardiac remodelling is a fundamental response to hypertension, myocardial infarction and chronic heart failure, and involves cardiac fibroblast proliferation and production of extracellular matrix components such as collagen. The present study was performed to examine the role of endogenous atrial natriuretic peptide (ANP) as a possible paracrine factor for cardiac fibroblasts, and to examine the effects of three neutral endopeptidase (NEP) inhibitors, thiorphan, phosphoramidon and ONO‐BB‐039‐02 (ONO‐BB) on endogenous ANP‐induced changes in collagen synthesis by cultured neonatal rat cardiac fibroblasts. Each NEP inhibitor singly had no significant effect on collagen synthesis by cardiac fibroblasts, except for maximum concentration (10 −3   M ) of thiorphan. Exogenous ANP inhibited collagen synthesis in a concentration‐dependent manner (10 −8 –10 −6   M ). Thiorphan (10 −4 and 10 −3   M ) and phosphoramidon (10 −5 and 10 −4   M ) enhanced the ANP (10 −7   M )‐induced decrease in collagen synthesis. ONO‐BB (10 −5 and 10 −4   M ) slightly enhanced the ANP‐induced decrease in collagen synthesis. Myocyte‐conditioned medium (MC‐CM), as well as exogenous ANP, inhibited collagen synthesis dose‐dependently. The decrease in collagen synthesis at 100% MC‐CM was augmented by thiorphan (10 −3   M ), phosphoramidon (10 −4   M ) and ONO‐BB (10 −4   M ). HS‐142‐1, a natriuretic peptide receptor antagonist, significantly reduced the MC‐CM plus thiorphan‐ and MC‐CM plus ONO‐BB‐induced decrease in collagen synthesis, by 92 and 62%, respectively and showed a tendency to attenuate the MC‐CM plus phosphoramidon‐induced decrease in collagen synthesis by 40%. Our observations suggested that endogenous ANP released from cardiomyocytes inhibited collagen synthesis as a paracrine factor and that NEP inhibitors enhanced the activity of this peptide in cardiac fibroblasts. British Journal of Pharmacology (2000) 131 , 1204–1210; doi: 10.1038/sj.bjp.0703679
    Type of Medium: Online Resource
    ISSN: 0007-1188 , 1476-5381
    Language: English
    Publisher: Wiley
    Publication Date: 2000
    detail.hit.zdb_id: 2029728-2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...